Company intelligence / Profile preview

Shandong Ruiyang Pharmaceutical Technology

Jinan, Shandong Province, China

Ownership: Private
Development stage: Commercial

Overview

Shandong Ruiyang Pharmaceutical Technology is a fine chemicals manufacturer specializing in crystalline sorbitol and related sugar polyols. Their products are used primarily as pharmaceutical excipients, in medical fields, food manufacturing, aquatic product processing, and cosmetics. The company emphasizes advanced technology for high-quality production and ongoing R&D investment to maintain leadership in the national sugar polyol industry.

Therapeutic areas: OtherEndocrinologyDermatology
Modalities: Small moleculeExcipient/ingredient for medical and food applications
Industry: Chemicals & Materials

Drug pipeline

3 assets

dacarbazine

Commercial

Indications: Cancer

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shandong Ruiyang Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Ruiyang Pharmaceutical Technology.

Explore the full profile